Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents

Author:

Zagouri Flora1,Kastritis Efstathios1,Symeonidis Argiris S.2,Giannakoulas Nikolaos3,Katodritou Eirini4,Delimpasi Sosana5,Repousis Panagiotis6,Terpos Evangelos1,Dimopoulos Meletios A.1,

Affiliation:

1. Department of Clinical Therapeutics; School of Medicine; National and Kapodistrian University of Athens; Athens Greece

2. Hematology Division; Department of Internal Medicine; University of Patras; Patras Greece

3. Department of Hematology; School of Medicine; University of Thessaly; Larisa Greece

4. Department of Hematology; Theagenion Cancer Center; Thessaloniki Greece

5. Department of Hematology and Bone Marrow Transplantation Unit; Evangelismos Hospital; Athens Greece

6. Department of Hematology; Metaxa Cancer Hospital; Piraeus Greece

Publisher

Wiley

Subject

Hematology,General Medicine

Reference22 articles.

1. IgD multiple myeloma. Review of 133 cases;Jancelewicz;Arch Intern Med,1975

2. Prognostic factors in IgD myeloma: a study of 21 cases;Fibbe;Scand J Haematol,1984

3. Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases;Bladé;J Clin Oncol,1994

4. IgD myeloma: clinical, biological and laboratory features;Sinclair;Clin Lab,2002

5. A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients;Shimamoto;Eur J Haematol,1991

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3